Medifast, Inc. provided earnings guidance for the full year 2023. For the year, the company expects revenue to be in the range of $1,050 million to $1,070 million and full-year 2023 diluted EPS to be in the range of $8.65to $9.55.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.36 USD | -4.25% | -21.13% | -60.79% |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.79% | 294M | |
+13.21% | 8.15B | |
-0.47% | 7.23B | |
+12.30% | 6.65B | |
-6.99% | 3.72B | |
-7.20% | 3.64B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-43.12% | 863M | |
-15.02% | 799M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast, Inc. Provides Earnings Guidance for the Full Year 2023